Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Ensysce Biosciences, Inc.

Ensysce Biosciences Announces Positive Bioequivalence (BE) Study Data of Novel "TAAP" Opioid PF614 and Provides Timing of Corporate Update Call
From Ensysce Biosciences, Inc.
Via AccessWire
Exposures Product Safety
Tickers ENSC ENSCW
Ensysce Biosciences Announces Initial Patients Dosed of First Human Abuse Potential Study
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
Ensysce Biosciences Secures $8 Million Convertible Note Financing
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
Ensysce Biosciences Receives Notice of Award for 4th Year of Funding for Its Multi-Pill Abuse Resistance (MPAR(TM)) Platform
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
Ensysce Biosciences Reminds Shareholders to Vote At Upcoming 2022 Virtual Annual Shareholder Meeting
From Ensysce Biosciences, Inc.
Via AccessWire
Topics Death Intellectual Property
Exposures Death Intellectual Property
Tickers ENSC ENSCW
Ensysce Biosciences Announces Initiation of First Human Abuse Potential Study
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
Ensysce Biosciences Provides Business Update and Reports First Quarter 2022 Financial Results
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
Ensysce Biosciences Releases 2021 Annual Shareholder Letter
From Ensysce Biosciences, Inc.
Via AccessWire
Topics Death Intellectual Property Regulatory Compliance
Exposures Death Intellectual Property Legal
Tickers ENSC ENSCW
Dr. Lynn Kirkpatrick, Invited Speaker at SMi 22nd Annual Pain Therapeutics Conference in London UK
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
Ensysce Biosciences Announces Appointment of Dr. Nily Osman as Chief Medical Officer
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
Ensysce Biosciences Announces Fourth Quarter and Full Year 2021 Earnings Release Date and Timing of Corporate Update Call
From Ensysce Biosciences, Inc.
Via AccessWire
Tickers ENSC ENSCW
Ensysce Biosciences Sets September 2021 Conference Schedule
From Ensysce Biosciences, Inc.
Via AccessWire
Topics Death Intellectual Property Regulatory Compliance
Exposures Death Intellectual Property Legal
Tickers ENSC ENSCW
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.